Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
BIO-TECHNE Corp (TECH)
|
Add to portfolio |
|
|
Price: |
$487.79
| | Metrics |
OS: |
158.2
|
M
| |
14
|
% ROE
|
Market cap: |
$77.2
|
B
| |
27
|
% ROIC
|
Net debt:
|
$146
|
M
| |
0.4
|
x Debt/EBITDA
|
EV:
|
$77.3
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
$406
|
M
| |
190.3
|
x EV/EBITDA
|
EBIT
|
$299
|
M
| |
258.6
|
x EV/EBIT
|
EPS |
$3.42
| |
142.7
|
x P/E
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Jun-30-23 | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 |
Revenues | 1,136.7 | 1,105.6 | 931.0 | 738.7 | 714.0 | 643.0 | 563.0 | 499.0 |
Revenue growth | 2.8% | 18.7% | 26.0% | 3.5% | 11.0% | 14.2% | 12.8% | 10.3% |
Cost of goods sold | 366.9 | 349.1 | 298.2 | 255.5 | 240.5 | 210.9 | 188.5 | 162.4 |
Gross profit | 769.8 | 756.5 | 632.9 | 483.2 | 473.5 | 432.1 | 374.5 | 336.7 |
Gross margin | 67.7% | 68.4% | 68.0% | 65.4% | 66.3% | 67.2% | 66.5% | 67.5% |
Selling, general and administrative | 378.4 | 372.8 | 325.0 | 260.6 | 264.4 | 240.6 | 200.4 | 140.9 |
Research and development | 92.5 | 87.1 | 70.6 | 65.2 | 62.4 | 55.3 | 53.5 | 45.2 |
EBITA | 376.4 | 370.7 | 237.3 | 157.4 | 205.4 | 136.2 | 120.6 | 180.0 |
EBITA margin | 33.1% | 33.5% | 25.5% | 21.3% | 28.8% | 21.2% | 21.4% | 36.1% |
Amortization of intangibles | 77.5 | 74.1 | | | 58.7 | | | 29.4 |
EBIT | 298.9 | 296.6 | 237.3 | 157.4 | 146.7 | 136.2 | 120.6 | 150.6 |
EBIT margin | 26.3% | 26.8% | 25.5% | 21.3% | 20.5% | 21.2% | 21.4% | 30.2% |
Pre-tax income | 338.7 | 301.4 | 148.2 | 276.5 | 112.0 | 126.0 | 112.0 | 147.5 |
Income taxes | 53.2 | 38.3 | 8.6 | 47.2 | 15.9 | -0.2 | 35.9 | 43.0 |
Tax rate | 15.7% | 12.7% | 5.8% | 17.1% | 14.2% | | 32.0% | 29.2% |
Net income | 285.3 | 272.1 | 140.4 | 229.3 | 96.1 | 126.2 | 76.1 | 104.5 |
Net margin | 25.1% | 24.6% | 15.1% | 31.0% | 13.5% | 19.6% | 13.5% | 20.9% |
|
Diluted EPS | $1.76 | $1.66 | $0.87 | $5.82 | $2.47 | $3.31 | $2.03 | $2.80 |
Shares outstanding (diluted) | 161.9 | 164.1 | 161.9 | 39.4 | 38.9 | 38.1 | 37.5 | 37.3 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|